Frazier Healthcare Partners — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Mirum Pharmaceuticalsmirumpharma.comin𝕏NASDAQ: MIRMSeries A · Nov 2018 · $120M
Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.
BiotechHealthtechSan Diego, US
Chris Peetz(Co-founder & Chief Executive Officer)inEric Bjerkholt(Executive Officer)inPeter Radovich(Executive Officer)in
BoardPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)
Co-investorsChiesi VenturesFrazier Life SciencesNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersNorwest Venture Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.